Skip to content
ppharmaranks
Menu

Best Alkylating Drug for brain neoplasms

Top-rated pick: Gleostine — pharmaranks score 70/100, the highest of the 4 Alkylating Drug drugs used for brain neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for brain neoplasms or the full Alkylating Drug class. Not medical advice — always consult a professional.

Quick answer: Of the 4 alkylating drug drugs we rate for brain neoplasms, none are yet flagged as generics in our price data, and most are capsule. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for brain neoplasms; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

How alkylating drug work

Alkylating chemotherapy drugs attach chemical groups to a cell's DNA, forming cross-links that lock the two DNA strands together. This damage stops the cell from copying its DNA and dividing, which triggers it to die; because they are not limited to one phase of the cell cycle, they can act on cells whether or not they are actively dividing.

Source: Cyclophosphamide — StatPearls, NCBI Bookshelf (NIH)

Other drug classes for brain neoplasms

Top alkylating drug for brain neoplasms: 1. Gleostine · 2. Gliadel · 3. Bicnu

Best-rated Alkylating Drug for brain neoplasms, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
270/100View →
3Not yet ratedView →
4Not yet ratedView →

Full ranking · 4 drugs

Frequently asked

What is the best alkylating drug for brain neoplasms?
By our independent recall-safety rating — not an efficacy measure — gleostine ranks highest among Alkylating Drug drugs used for brain neoplasms. Always consult a professional.
Which alkylating drug drugs treat brain neoplasms?
pharmaranks lists 4 Alkylating Drug products used for brain neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.